Quest Pharmatech Inc V.QPT

Alternate Symbol(s): QPTFF

Healthcare Biotechnology

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. It also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.

TSXV:QPT - Post by User

Quest Pharmatech Inc

Bullboard Posts

Comment by SmallPenny14on Feb 24, 2017 4:08pm

130 Views

Post# 25891333

RE:RE:RE:Favor

Good to hear.
I have been a share holder for a while now, and I do believe this company has a bright future.
But it frustrates me that they do not keep the share holders in the loop....And as of late, they haven't really released any press releases at all.

And a couple of the things I would personally like to know is:

- How are the sales for their Bellus skin serum going?
- And how are their other treatments going?
- End of the previous fiscal year should be filed soon (ended Jan. 31/17) and if there are any highlights.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario